All the news Showing 10 of 34 articles from: Non-nucleoside Ns5B polymerase inhibitorsGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Boehringer Ingelheim Expands Investigation of Interferon-free Hepatitis C Treatment Regimens to Reach More Patient Types through Presidio Pharmaceuticals Clinical Collaboration PR Newswire (press release) / 10 September 2013 2 HCV Drugs Work Well Without Interferon MedPage Today Gastroenterology / 15 August 2013 Investigational noninterferon HCV treatment effective across patient groups Internal Medicine News / 30 May 2013 AbbVie's Investigational HCV Regimen Receives Breakthrough Therapy Designation from the U.S. Food and Drug Administration AbbVie press release / 07 May 2013 Daclatasvir + asunaprevir + BMS-791352 looks promising as interferon-free combination Liz Highleyman / 02 May 2013 An all-oral regimen containing three next-generation antivirals taken for either 12 or 24 weeks produced sustained virological response in more than 90% of previously untreated genotype 1 chronic hepatitis C patients in a ... Hep C quad regimens quashed, but some components go forward Liz Highleyman / 29 April 2013 A pair of four-drug interferon-based hepatitis C regimens worked well, but further study has been halted after a few patients experienced serious adverse events, according to a set of presentations last week at ... AbbVie interferon-free combination cures over 90% of hepatitis C genotype 1 Keith Alcorn / 26 April 2013 A four-drug combination of direct acting antivirals developed by AbbVie cured hepatitis C infection in over 90% of participants in the AVIATOR study, without the need for the use of interferon, researchers reported ... Bristol-Myers oral hepatitis C regimen looks competitive - study Reuters / 24 April 2013 AbbVie hepatitis C drugs knock out virus at eight weeks Yahoo News / 24 April 2013 Phase II all-oral combination studies of simeprevir, TMC647055 and IDX719 for the treatment of hepatitis C to be initiated shortly Medivir press release / 29 January 2013 ← Prev1234Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive